Will this eczema cream cause Sun-Related allergies? new study investigates
NCT ID NCT04807751
First seen May 08, 2026 · Last updated Jun 22, 2026 · Updated 5 times
Summary
This completed Phase 1 trial tested whether delgocitinib cream, a potential eczema treatment, can cause a UV-light-induced allergic skin reaction (photoallergy). Sixty healthy adults had the cream or a placebo applied to their skin and were then exposed to UV light. Researchers checked for skin reactions to determine the cream's photoallergic potential.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bioskin Research Center Dermatology
Hamburg, 20095, Germany
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
delgocitinib cream
What this could lead to
If successful, this study could confirm that delgocitinib cream is safe to use without causing UV-related allergic skin reactions.
What could go wrong
This is an early-phase safety study in healthy people, not patients. It only tests for photoallergy and does not evaluate effectiveness for any disease.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.